BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16541466)

  • 1. Interferon regulatory factor-1 gene deletion decreases glomerulonephritis in MRL/lpr mice.
    Reilly CM; Olgun S; Goodwin D; Gogal RM; Santo A; Romesburg JW; Ahmed SA; Gilkeson GS
    Eur J Immunol; 2006 May; 36(5):1296-308. PubMed ID: 16541466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Tesch G; Kinoshita K; Maron R; Weiner HL; Kelley VR
    J Immunol; 1999 Dec; 163(12):6884-91. PubMed ID: 10586090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
    Patole PS; Gröne HJ; Segerer S; Ciubar R; Belemezova E; Henger A; Kretzler M; Schlöndorff D; Anders HJ
    J Am Soc Nephrol; 2005 May; 16(5):1326-38. PubMed ID: 15772251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR
    J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice.
    Haas C; Ryffel B; Le Hir M
    J Immunol; 1997 Jun; 158(11):5484-91. PubMed ID: 9164971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN.
    Lee HJ; Oh YK; Rhee M; Lim JY; Hwang JY; Park YS; Kwon Y; Choi KH; Jo I; Park SI; Gao B; Kim WH
    J Mol Biol; 2007 Jun; 369(4):967-84. PubMed ID: 17475277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice.
    Wenderfer SE; Ke B; Hollmann TJ; Wetsel RA; Lan HY; Braun MC
    J Am Soc Nephrol; 2005 Dec; 16(12):3572-82. PubMed ID: 16207826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
    Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.
    Sadanaga A; Nakashima H; Masutani K; Miyake K; Shimizu S; Igawa T; Sugiyama N; Niiro H; Hirakata H; Harada M
    Arthritis Rheum; 2005 Dec; 52(12):3987-96. PubMed ID: 16320345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice.
    Sadanaga A; Nakashima H; Akahoshi M; Masutani K; Miyake K; Igawa T; Sugiyama N; Niiro H; Harada M
    Arthritis Rheum; 2007 May; 56(5):1618-28. PubMed ID: 17469144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible co-stimulator null MRL-Faslpr mice: uncoupling of autoantibodies and T cell responses in lupus.
    Zeller GC; Hirahashi J; Schwarting A; Sharpe AH; Kelley VR
    J Am Soc Nephrol; 2006 Jan; 17(1):122-30. PubMed ID: 16291836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice.
    Tada Y; Nagasawa K; Ho A; Morito F; Koarada S; Ushiyama O; Suzuki N; Ohta A; Mak TW
    J Immunol; 1999 Sep; 163(6):3153-9. PubMed ID: 10477582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
    J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
    Matsumoto K; Watanabe N; Akikusa B; Kurasawa K; Matsumura R; Saito Y; Iwamoto I; Saito T
    Arthritis Rheum; 2003 Feb; 48(2):486-94. PubMed ID: 12571859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontline: interferon regulatory factor-1 as a protective gene in intestinal inflammation: role of TCR gamma delta T cells and interleukin-18-binding protein.
    Siegmund B; Sennello JA; Lehr HA; Senaldi G; Dinarello CA; Fantuzzi G
    Eur J Immunol; 2004 Sep; 34(9):2356-64. PubMed ID: 15307168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
    J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
    Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K
    Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin disease is prevented but nephritis is accelerated by multiple pregnancies in autoimmune MRL/LPR mice.
    Kökény G; Godó M; Nagy E; Kardos M; Kotsch K; Casalis P; Bodor C; Rosivall L; Volk HD; Zenclussen AC; Hamar P
    Lupus; 2007; 16(7):465-77. PubMed ID: 17670844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of inducible costimulator in the development of lupus in MRL/lpr mice.
    Tada Y; Koarada S; Tomiyoshi Y; Morito F; Mitamura M; Haruta Y; Ohta A; Nagasawa K
    Clin Immunol; 2006 Aug; 120(2):179-88. PubMed ID: 16616645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells.
    Parietti V; Monneaux F; Décossas M; Muller S
    Arthritis Rheum; 2008 Jun; 58(6):1751-61. PubMed ID: 18512811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.